261 related articles for article (PubMed ID: 17466020)
21. Both host prion protein 131-188 subregion and prion strain characteristics regulate glycoform of PrP Sc.
Yokoyama T; Shimada K; Masujin K; Iwamaru Y; Imamura M; Ushiki YK; Kimura KM; Itohara S; Shinagawa M
Arch Virol; 2007; 152(3):603-9. PubMed ID: 17106625
[TBL] [Abstract][Full Text] [Related]
22. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
23. Synaptic prion protein immuno-reactivity in the rodent cerebellum.
Haeberlé AM; Ribaut-Barassin C; Bombarde G; Mariani J; Hunsmann G; Grassi J; Bailly Y
Microsc Res Tech; 2000 Jul; 50(1):66-75. PubMed ID: 10871550
[TBL] [Abstract][Full Text] [Related]
24. Prion protein glycosylation.
Lawson VA; Collins SJ; Masters CL; Hill AF
J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
[TBL] [Abstract][Full Text] [Related]
25. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
26. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
27. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural localization of prion proteins: physiological and pathological implications.
Fournier JG; Escaig-Haye F; Grigoriev V
Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
[TBL] [Abstract][Full Text] [Related]
29. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
30. Understanding the natural variability of prion diseases.
Geissen M; Krasemann S; Matschke J; Glatzel M
Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
[TBL] [Abstract][Full Text] [Related]
31. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
32. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
Albanese V; Lawson VA; Hill AF; Cappai R; Di Guardo G; Staikopoulos V; Thacker M; Furness JB; Chiocchetti R
Auton Neurosci; 2008 Jun; 140(1-2):17-23. PubMed ID: 18358791
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan.
Hagiwara K; Yamakawa Y; Sato Y; Nakamura Y; Tobiume M; Shinagawa M; Sata T
Jpn J Infect Dis; 2007 Sep; 60(5):305-8. PubMed ID: 17881874
[TBL] [Abstract][Full Text] [Related]
34. Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Morel N; Andréoletti O; Grassi J; Clément G
Rapid Commun Mass Spectrom; 2007; 21(24):4093-100. PubMed ID: 18008391
[TBL] [Abstract][Full Text] [Related]
35. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
36. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
37. The neurochemical nature of PrP(c)-containing cells in the rat brain.
Moleres FJ; Velayos JL
Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
[TBL] [Abstract][Full Text] [Related]
38. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
39. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
40. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
